Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Clinical results reported for Novo Nordisk insulinotropic agent

June 11, 1997

NN-304, a long-acting insulin analogue in preclinical testing

June 10, 1997

Skelid introduced in the U.S.

June 10, 1997

New antidiabetic agent from Japan Tobacco

June 10, 1997

Agent for gastroparesis in diabetic patients

June 10, 1997

Studies reported on absorption of the insulin analogue HOE-901

June 10, 1997

BRL-49653: Profile of a potential new antidiabetic agent

June 10, 1997

BTS-67582 preclinical and clinical trials results

June 10, 1997

Promising clinical results reported for Flt3 ligand as stem cell mobilizer

June 9, 1997

TKT reaches milestone in second Gene Activation collaboration with HMR

June 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...